Literature DB >> 22395347

Is there any benefit from expanding the criteria for the resection of hepatocellular carcinoma in cirrhotic liver? Experience from a developing country.

Danijel A Galun1, Predrag Bulajic, Marinko Zuvela, Dragan Basaric, Tatjana Ille, Miroslav N Milicevic.   

Abstract

BACKGROUND: Patients with large-size (>10 cm) hepatocellular carcinoma (HCC) in Child B cirrhosis are usually excluded from curative treatment, i.e., hepatic resection, because of marginal liver function and poor outcome. This study was designed to evaluate the feasibility of the radiofrequency (RF)-assisted sequential "coagulate-cut liver resection technique" in expanding the criteria for resection of large HCC in cirrhotic livers with impaired liver function.
METHODS: Forty patients with Child-Pugh A or B cirrhosis underwent liver resection from December 1, 2001 to December 31, 2008. Of these, 20 patients (13 Child-Pugh A and 7 Child-Pugh B) with advanced stage HCC (stage B and C according to Barcelona-Clinic Liver Cancer Group) underwent major liver resection. The two groups were comparable in terms of patient age, liver cirrhosis etiology, tumor number, and size.
RESULTS: All resections were performed without the Pringle maneuver. There was no significant difference found between the two groups regarding resection time, perioperative transfusion, postoperative complications, hospital stay, and day 7 values of hemoglobin and liver enzymes. Likewise, there was no significant difference found in the overall survival between Child A and Child B patients who underwent major liver resection
CONCLUSIONS: RF-assisted sequentional "coagulate-cut liver resection technique" may be a viable alternative for management of patients with advanced HCC in cirrhotic liver with impaired function.

Entities:  

Mesh:

Year:  2012        PMID: 22395347     DOI: 10.1007/s00268-012-1544-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  37 in total

Review 1.  Current strategy for staging and treatment: the BCLC update and future prospects.

Authors:  Alejandro Forner; María E Reig; Carlos Rodriguez de Lope; Jordi Bruix
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

2.  Randomized clinical trial of radiofrequency-assisted versus clamp-crushing liver resection.

Authors:  L Lupo; A Gallerani; P Panzera; F Tandoi; G Di Palma; V Memeo
Journal:  Br J Surg       Date:  2007-03       Impact factor: 6.939

3.  A radiofrequency-assisted minimal blood loss liver parenchyma dissection technique.

Authors:  Miroslav Milićević; Predrag Bulajić; Marinko Zuvela; Christos Dervenis; Dragan Basarić; Danijel Galun
Journal:  Dig Surg       Date:  2007       Impact factor: 2.588

Review 4.  Treatment of large and advanced hepatocellular carcinoma.

Authors:  Eddie K Abdalla; Alban Denys; Kiyoshi Hasegawa; Thomas W T Leung; Masatoshi Makuuchi; Ravi Murthy; Dario Ribero; Daria Zorzi; Jean-Nicolas Vauthey; Guido Torzilli
Journal:  Ann Surg Oncol       Date:  2008-01-31       Impact factor: 5.344

5.  Radiofrequency-assisted liver resection does not induce severe liver damage.

Authors:  Miroslav Milicevic; Predrag Bulajic
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

6.  Effects of intermittent Pringle's manoeuvre on cirrhotic compared with normal liver.

Authors:  Y Sugiyama; Y Ishizaki; H Imamura; H Sugo; J Yoshimoto; S Kawasaki
Journal:  Br J Surg       Date:  2010-07       Impact factor: 6.939

Review 7.  Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

8.  Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.

Authors:  Takeaki Ishizawa; Kiyoshi Hasegawa; Taku Aoki; Michiro Takahashi; Yosuke Inoue; Keiji Sano; Hiroshi Imamura; Yasuhiko Sugawara; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Gastroenterology       Date:  2008-03-08       Impact factor: 22.682

9.  Simple clinical prognostic model for hepatocellular carcinoma in developing countries and its validation.

Authors:  Chee Kiat Tan; Ngai Moh Law; Han Seong Ng; David Machin
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

10.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740

View more
  7 in total

Review 1.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

2.  Efficiency and safety of radiofrequency-assisted hepatectomy for hepatocellular carcinoma with cirrhosis: A single-center retrospective cohort study.

Authors:  Fan Zhang; Jun Yan; Xiao-Bin Feng; Feng Xia; Xiao-Wu Li; Kuan-Sheng Ma; Ping Bie
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

Review 3.  Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion.

Authors:  Jian-Hong Zhong; A Chapin Rodríguez; Yang Ke; Yan-Yan Wang; Lin Wang; Le-Qun Li
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

Review 4.  Controversies and evidence of hepatic resection for hepatocellular carcinoma.

Authors:  Jian-Hong Zhong; Guido Torzilli; Hao Xing; Chao Li; Jun Han; Lei Liang; Han Zhang; Shu-Yang Dai; Le-Qun Li; Feng Shen; Tian Yang
Journal:  BBA Clin       Date:  2016-10-11

5.  Short- and Long-Term Outcomes After Hepatectomy in Elderly Patients with Hepatocellular Carcinoma: An Analysis of 229 Cases from a Developing Country.

Authors:  Danijel Galun; Aleksandar Bogdanovic; Marko Zivanovic; Marinko Zuvela
Journal:  J Hepatocell Carcinoma       Date:  2021-03-23

Review 6.  Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective.

Authors:  Danijel Galun; Dragana Mijac; Aleksandar Filipovic; Aleksandar Bogdanovic; Marko Zivanovic; Dragan Masulovic
Journal:  J Pers Med       Date:  2022-01-24

7.  Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative-intent surgery for hepatocellular carcinoma: experience from a developing country.

Authors:  Danijel Galun; Aleksandar Bogdanovic; Jelena Djokic Kovac; Predrag Bulajic; Zlatibor Loncar; Marinko Zuvela
Journal:  Cancer Manag Res       Date:  2018-05-04       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.